1459P Analysis of long-term efficacy outcomes from the CheckMate 025 (CM 025) trial comparing nivolumab (NIVO) vs everolimus (EVE) based on ≥ 7 years (yrs) of follow-up in pre-treated patients (pts) with advanced renal cell carcinoma (aRCC)
| Autor: | B. Escudier, R.J. Motzer, M. Dyer, J.R. May, F. Ejzykowicz, M. Kurt, C-W. Lee, P. Wang, E. Testa, D.J. Sharpe, S. George, N. Tannir |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S1212 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.07.1562 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|